Clinical trials
Completed Multiple Myeloma trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 9 |
| Amgen | 7 |
| Celgene | 5 |
| Sanofi | 3 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene Corporation | 1 |
| InSightec | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Janssen-Cilag Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 35 |
| Recurrence | 6 |
| Neoplasms, Plasma Cell | 5 |
| Bone Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms | 2 |
| Smoldering Multiple Myeloma | 2 |
| Blood Protein Disorders | 1 |
| Bone Diseases | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.